Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma)

Genes and Immunity

Volumn 2, Issue 5, 2001, Pages 273-275

  Johnson, R W ^a   Reveille, J D ^a   McNearney, T ^b   Fischbach, M ^c   Friedman, A W ^a   Ahn, C ^a   Arnett, F C ^a   Tan, F K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Fibrosis; Genetics; Matrix metalloproteinase 1; Scleroderma; Systemic sclerosis

Indexed keywords

INTERSTITIAL COLLAGENASE;

ARTICLE; ENZYMOLOGY; GENETICS; HUMAN; PHYSIOLOGY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

HUMANS; MATRIX METALLOPROTEINASE 1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SCLERODERMA, SYSTEMIC;

EID: 0035434770     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363768     Document Type: Article

References (15)

1. Trojanowska M, Leroy EC, Eckes B, Krieg T. Pathogenesis of fibrosis: type I collagen and the skin. J Mol Med 1998; 76: 266-274.
2. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996; 22: 647-674.
3. Borden P, Heller R. Transcriptional control of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryotic Gene Express 1997; 7: 159-178.
4. MacDougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995; 14: 351-362.
5. Yoshihara Y, Nakamura H, Obata K et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000; 59: 455-461.
6. Kuroda K, Shinkai H. Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997; 289: 567-572.
7. Xiaodong Z, Tan FK, Xiong M, Milewicz DM, Arnett FC. Comparisions of fibroblasts gene expression profiles in systemic sclerosis, normal controls, scleromyxedema, and eosinophilic fasciitis. Arthritis Rheum 2000; 41 (Suppl): S259 (Abst. 1154).
8. Rutter JL, Mitchell TF, Buttice G et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter create an ets binding site and augments transcription. Cancer Res 1998; 58: 5321-5325.
9. Reveille JD, Fischbach M, McNearney T et al. Systemic sclerosis in three ethnic groups: a combination of clinical, sociodemogrphic, serologic and immunogentic determinants. Semin Arthritis Rheum 2001; 30: 332-346.
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
11. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 2: 202-205.
12. Clements P, Lachenbruch P, Seibold JR et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-1285.
13. Arnett FC, Reveille JD, Goldstein R et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serologic, and clinical analysis. Arthritis Rheum 1996; 39: 1151-1160.
14. Uria JA, Jimenez MG, Balbin M, Freije JMP, Lopez-Otin C. Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 1998; 273: 9769-9777.
15. Rutter JL, Benhow U, Coon CI, Brinkerhoff CE. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1β (IL-1B) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem 1997; 66: 322-336.